Abstract
We have reviewed our experience with radioinmunoassays of the insulin-like growth factors, IGF-I and II, to determine their utility in the evaluation of short stature. IGF-I and II were treasured in normal (NL) (height 5-95%), normal short (NS) (height > 2 s.d. below mean, GH peak < 7ng/ml) and growth hormone deficient (GHD)children by radioimmunoassay using the NIADDK anti-serum for IGF-I and a specific antibody to the C-peptide region of IGF-II. An age-related boundary for IGF-I and a level of 300ng/ml for IGF-II were used to classify values as normal or low. Results are given in the table as [low values]/[total per group].
IGF-I is a far better indicator of GHD than IGF-II. Using a criterion of either low IGF-I or II, 62/65 (95%) of GHD cases and 18/195 (9%) of NL would have been identified. 5/7 false positives for IGF-I occurred below age 5 and 4/5 false negatives occurred above age 8. Interestingly, the proportion of low values for both IGF-I and II in the NS group are similar to those observed for the GHD group. We conclude that IGF-I and to a lesser extent IGF-II levels are useful in identifying a child with possible GHD. Our data also demonstrate significant overlap in IGF-I and II levels in GHD and NS children, suggesting that a subset of NS has abnormalities in physiologic GH secretion which are not revealed by provocative testing.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, P., Wilson, D., Hintz, R. et al. 463 CLINICAL RELEVRNCE OF THE INSULIN-LIKE GROWTH FACTORS. Pediatr Res 19, 188 (1985). https://doi.org/10.1203/00006450-198504000-00493
Issue date:
DOI: https://doi.org/10.1203/00006450-198504000-00493
